The journey from laboratory innovation to bedside care requires rigorous validation, regulatory clearance, and scalable production. Translational and clinical applications in regenerative medicine emphasize how preclinical successes evolve into clinically viable therapies. It involves refining delivery systems, validating efficacy in human models, and aligning treatments with patient-specific needs. Technologies like 3D-printed grafts, cell-based therapies, and gene-modified tissues are now being tested in controlled trials. Translational and clinical applications also address manufacturing challenges, ethical oversight, and physician training to ensure successful implementation. As more therapies reach early-phase and advanced clinical stages, the path to accessible and reliable regenerative solutions is becoming clearer and more standardized globally.
Title : The era of artificial intelligence (AI) and its use in regenerative medicine
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : The role of gingival fibroblasts in periodontal diseases and regeneration
Katarzyna Gawron, Medical University of Silesia in Katowice, Poland
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Role of textile materials in tissue engineering and regenerative medicine
Gokarneshan Narayanan, SSM College of Engineering (Formerly), India
Title : Induction of neo angiogenesis: A way forward for reversing necrosis in complex wounds in orthopaedic practice
Sandeep Shrivastava, Datta Meghe Institute of Medical Sciences, India
Title : Silk-derived sericin at the interface of atopic dermatitis and wound healing: Modulation of inflammation and epidermal repair
Marek Konop, Medical University of Warsaw, Poland